Literature DB >> 25911583

Primary afferent neurons express functional delta opioid receptors in inflamed skin.

Jill-Desiree Brederson1, Christopher N Honda2.   

Abstract

Peripherally-restricted opiate compounds attenuate hyperalgesia in experimental models of inflammatory pain, but have little discernable effect on nociceptive behavior in normal animals. This suggests that activation of opioid receptors on peripheral sensory axons contributes to decreased afferent activity after injury. Previously, we reported that direct application of morphine to cutaneous receptive fields decreased mechanical and heat-evoked responses in a population of C-fiber nociceptors in inflamed skin. Consistent with reported behavioral studies, direct application of morphine had no effect on fiber activity in control skin. The aim of the present study was to determine whether mechanical responsiveness of nociceptors innervating inflamed skin was attenuated by direct activation of delta opioid receptors (DORs) on peripheral terminals. An ex vivo preparation of rat plantar skin and tibial nerve was used to examine effects of a selective DOR agonist, deltorphin II, on responsiveness of single fibers innervating inflamed skin. Electrical recordings were made eighteen hours after injection of complete Freund's adjuvant into the hindpaw. Deltorphin II produced an inhibition of the mechanical responsiveness of single fibers innervating inflamed skin; an effect blocked by the DOR-selective antagonist, naltrindole. The population of units responsive to deltorphin II was identified as consisting of C fiber mechanical nociceptors.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Deltorphin; Electrophysiology; Inflammation; Opiate; Peripheral; Periphery

Mesh:

Substances:

Year:  2015        PMID: 25911583      PMCID: PMC4457631          DOI: 10.1016/j.brainres.2015.04.023

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  25 in total

1.  Co-administration of δ- and μ-opioid receptor agonists promotes peripheral opioid receptor function.

Authors:  Cicely L Schramm; Christopher N Honda
Journal:  Pain       Date:  2010-12       Impact factor: 6.961

Review 2.  Opioids and sensory nerves.

Authors:  Christoph Stein; Christian Zöllner
Journal:  Handb Exp Pharmacol       Date:  2009

3.  Deletion of delta-opioid receptor in mice alters skin differentiation and delays wound healing.

Authors:  Mei Bigliardi-Qi; Claire Gaveriaux-Ruff; Hayan Zhou; Clarisse Hell; Pierre Bady; Theo Rufli; Brigitte Kieffer; Paullorenz Bigliardi
Journal:  Differentiation       Date:  2006-04       Impact factor: 3.880

4.  Morphine priming in rats with chronic inflammation reveals a dichotomy between antihyperalgesic and antinociceptive properties of deltorphin.

Authors:  L Gendron; M J Esdaile; F Mennicken; H Pan; D O'Donnell; J-P Vincent; L A Devi; C M Cahill; T Stroh; A Beaudet
Journal:  Neuroscience       Date:  2006-10-19       Impact factor: 3.590

5.  Morphine directly inhibits nociceptors in inflamed skin.

Authors:  Heather N Wenk; Jill-Desiree Brederson; Christopher N Honda
Journal:  J Neurophysiol       Date:  2005-12-07       Impact factor: 2.714

6.  Involvement of peripheral mu opioid receptors in scratching behavior in mice.

Authors:  Atsuki Yamamoto; Yukio Sugimoto
Journal:  Eur J Pharmacol       Date:  2010-09-20       Impact factor: 4.432

7.  Deletion of mu- and kappa-opioid receptors in mice changes epidermal hypertrophy, density of peripheral nerve endings, and itch behavior.

Authors:  Mei Bigliardi-Qi; Claire Gaveriaux-Ruff; Katrin Pfaltz; Pierre Bady; Tommy Baumann; Theo Rufli; Brigitte L Kieffer; Paul L Bigliardi
Journal:  J Invest Dermatol       Date:  2006-12-21       Impact factor: 8.551

8.  Regulated proenkephalin expression in human skin and cultured skin cells.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Blazej Zbytek; Anna A Brozyna; Jackie Granese; Alexander Pisarchik; Andre Szczesniewski; Desmond J Tobin
Journal:  J Invest Dermatol       Date:  2010-12-30       Impact factor: 8.551

9.  Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.

Authors:  C M Cahill; A Morinville; M C Lee; J P Vincent; B Collier; A Beaudet
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

10.  Dissociation of the opioid receptor mechanisms that control mechanical and heat pain.

Authors:  Grégory Scherrer; Noritaka Imamachi; Yu-Qing Cao; Candice Contet; Françoise Mennicken; Dajan O'Donnell; Brigitte L Kieffer; Allan I Basbaum
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

View more
  4 in total

1.  Sex differences in kappa opioid receptor inhibition of latent postoperative pain sensitization in dorsal horn.

Authors:  Lilian Custodio-Patsey; Renée R Donahue; Weisi Fu; Joshua Lambert; Bret N Smith; Bradley K Taylor
Journal:  Neuropharmacology       Date:  2019-07-25       Impact factor: 5.250

2.  Combination of a δ-opioid Receptor Agonist and Loperamide Produces Peripherally-mediated Analgesic Synergy in Mice.

Authors:  Daniel J Bruce; Cristina D Peterson; Kelley F Kitto; Eyup Akgün; Sophia Lazzaroni; Phillip S Portoghese; Carolyn A Fairbanks; George L Wilcox
Journal:  Anesthesiology       Date:  2019-09       Impact factor: 7.892

3.  Overexpression of µ-Opioid Receptors in Peripheral Afferents, but Not in Combination with Enkephalin, Decreases Neuropathic Pain Behavior and Enhances Opioid Analgesia in Mouse.

Authors:  Amanda H Klein; Husam K Mohammad; Rabiah Ali; Brad Peper; Steven P Wilson; Srinivasa N Raja; Matthias Ringkamp; Sarah Sweitzer
Journal:  Anesthesiology       Date:  2018-05       Impact factor: 7.892

4.  Peripheral antinociceptive effects of a bifunctional μ and δ opioid receptor ligand in rat model of inflammatory bladder pain.

Authors:  Maia Terashvili; Bhavana Talluri; Watchareepohn Palangmonthip; Kenneth A Iczkowski; Patrick Sanvanson; Bidyut K Medda; Banani Banerjee; Christopher W Cunningham; Jyoti N Sengupta
Journal:  Neuropharmacology       Date:  2021-07-10       Impact factor: 5.273

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.